<DOC>
	<DOCNO>NCT01143974</DOCNO>
	<brief_summary>For patient resistant enthrycycline taxanes , standard regimen . Pemetrexed alone certain efficacy treatment advance breast cancer . Platin also effective drug advance breast cancer . The combination two drug may synergy treatment advanced breast cancer .</brief_summary>
	<brief_title>Trial Pemetrexed Combined With Cisplatin Treatment Advanced Breast Cancer</brief_title>
	<detailed_description>combination pemetrexed cisplatin treat advance breast cancer . Previous regimen 3 include enthrycycline taxanes ( paclitaxel and/or docetaxel )</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>1870 year old Resistant enthracycle taxanes Has measurable disease Has 3 previous chemotherapy regimen</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>progress free survival</keyword>
	<keyword>response rate</keyword>
	<keyword>safety</keyword>
</DOC>